Literature DB >> 27273899

Use of new imaging in detecting and monitoring ocular manifestations of the mucopolysaccharidoses.

Ahmed Javed1, Tariq Aslam1,2, Jane Ashworth1,2.   

Abstract

The aim of this review is to summate the eye involvement in patients with mucopolysaccharidoses (MPS) using current ocular imaging techniques, their advantages and disadvantages and how they may aid diagnosis, management and monitoring. We critically reviewed the current literature surrounding MPS and recent imaging technology as well as histology. Primary searches of PubMed and Web of Science were performed. We reviewed all papers on the topic published and summarized the findings of each medical device as well as the advantages and disadvantages of using these for the MPS patient. We discussed the potential of each of these devices to monitor potential ocular pathology in the MPS cohorts in the order of MPS subtype. We reviewed imaging techniques involving use of the Iris Camera, Pentacam, Optical Coherence Tomography (OCT) as well as ultrasound and Heidelberg OCT. The need for reliable objective quantification of eye findings in MPS has led to utilization of new imaging technologies described here, and future use will enhance our understanding of the unique eye features in MPS. In particular, we note that the Pentacam and iris camera are able to provide objective measurements of corneal haze and monitor ocular response to treatment.
© 2016 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  enzyme replacement therapy; hematopoietic stem cell transplantation; iris camera; mucopolysaccharidoses; ophthalmic imaging; optical coherence tomography; pentacam

Mesh:

Year:  2016        PMID: 27273899     DOI: 10.1111/aos.13098

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  5 in total

1.  Bull's eye maculopathy and subfoveal deposition in two mucopolysaccharidosis type I patients on long-term enzyme replacement therapy.

Authors:  Heather G Mack; R C Andrew Symons; Gerard de Jong
Journal:  Am J Ophthalmol Case Rep       Date:  2017-10-04

Review 2.  Glaucoma in mucopolysaccharidoses.

Authors:  Weijing Kong; Jing Zhang; Cheng Lu; Yingxue Ding; Yan Meng
Journal:  Orphanet J Rare Dis       Date:  2021-07-15       Impact factor: 4.123

Review 3.  Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology.

Authors:  Christiane S Hampe; Julie B Eisengart; Troy C Lund; Paul J Orchard; Monika Swietlicka; Jacob Wesley; R Scott McIvor
Journal:  Cells       Date:  2020-08-05       Impact factor: 6.600

Review 4.  Ocular features in mucopolysaccharidosis: diagnosis and treatment.

Authors:  Alessandra Del Longo; Elena Piozzi; Fiammetta Schweizer
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

Review 5.  Ophthalmological Findings in Mucopolysaccharidoses.

Authors:  Shizuka Tomatsu; Susanne Pitz; Ulrike Hampel
Journal:  J Clin Med       Date:  2019-09-14       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.